Concepedia

James M. Rinker

JM

Statistics

Publications

5

Citations

201

H-Index

5

Active since

1992

Affiliations

Sterling Research Group(Current)

James M. Rinker is an author at Sterling Research Group specializing in pharmacology, medicinal chemistry, and enzyme inhibition.

Publications per year

1992–2009

5

Publications

5

Synthesis and evaluation of azapeptide-derived inhibitors of serine and cysteine proteases

Todd L. Graybill, Mitchell J. Ross, Bruce R. Gauvin et al. · Bioorganic & Medicinal Chemistry Letters · 1992 · 56 citations

, , +14

Discovery and SAR of novel Naphthyridines as potent inhibitors of spleen tyrosine kinase (SYK)

Charles L. Cywin, Baoping Zhao, Daniel W. McNeil et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 48 citations · Full text

, , +16

Aspartyl .alpha.-((1-Phenyl-3-(trifluoromethyl)- pyrazol-5-yl)oxy)methyl Ketones as Interleukin-1.beta. Converting Enzyme Inhibitors. Significance of the P1 and P3 Amido Nitrogens for Enzyme-Peptide Inhibitor Binding

Roland E. Dolle, James M. Rinker, C. V. C. Prasad et al. · Journal of Medicinal Chemistry · 1994 · 45 citations

, , +12

Pyrido[2,3-<i>d</i>]pyrimidin-5-ones: A Novel Class of Antiinflammatory Macrophage Colony-Stimulating Factor-1 Receptor Inhibitors

Hui Huang, Daniel A. Hutta, James M. Rinker et al. · Journal of Medicinal Chemistry · 2009 · 41 citations · Full text

, , +17

3-chloro-4-carboxamido-6-arylpyridazines as a non-peptide class of interleukin-1β converting enzyme inhibitor

Roland E. Dolle, James M. Rinker, Tina Morgan Ross et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 11 citations

, , +7

1–5 of 5